Save information for later
Sign Up

Learn About Non-Langerhans-Cell Histiocytosis

What is the definition of Non-Langerhans-Cell Histiocytosis?
Non-Langerhans cell histiocytosis is a group of disorders in which too many white blood cells (histiocytes) that are not Langerhans cells build up in tissues or organs. Types of non-Langerhans cell histiocytosis include hemophagocytic lymphohistiocytosis, sinus histiocytosis, xanthogranuloma, reticulohistiocytoma, and dermatofibroma, among others.
What are the symptoms of Non-Langerhans-Cell Histiocytosis?
Symptoms of non-Langerhans cell histiocytosis include the growth of reddish-brown or reddish-yellow bumps in the skin that may affect internal organs, such as the lungs, liver, or kidneys.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Non-Langerhans-Cell Histiocytosis?
Treatment for non-Langerhans cell histiocytosis is usually not necessary unless internal organs are affected, in which case radiotherapy, surgery, or chemotherapy may be required.
Who are the top Non-Langerhans-Cell Histiocytosis Local Doctors?
Jithma P. Abeykoon
Elite in Non-Langerhans-Cell Histiocytosis
Hematology | Oncology | Hematology Oncology
Elite in Non-Langerhans-Cell Histiocytosis
Hematology | Oncology | Hematology Oncology

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
Languages Spoken:
English
Accepting New Patients

Jithma Abeykoon is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Abeykoon is rated as an Elite provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Waldenstrom Macroglobulinemia, Histiocytosis, Reticulohistiocytoma, Tissue Biopsy, and Bone Marrow Transplant. Dr. Abeykoon is currently accepting new patients.

Naval G. Daver
Elite in Non-Langerhans-Cell Histiocytosis
Hematology Oncology | Oncology | Hematology
Elite in Non-Langerhans-Cell Histiocytosis
Hematology Oncology | Oncology | Hematology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English
Offers Telehealth

Naval Daver is a Hematologist Oncology specialist and an Oncologist in Houston, Texas. Dr. Daver is rated as an Elite provider by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Franco M. Locatelli
Elite in Non-Langerhans-Cell Histiocytosis
Elite in Non-Langerhans-Cell Histiocytosis
Rome, IT 

Franco Locatelli practices in Rome, Italy. Mr. Locatelli is rated as an Elite expert by MediFind in the treatment of Non-Langerhans-Cell Histiocytosis. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Splenectomy.

What are the latest Non-Langerhans-Cell Histiocytosis Clinical Trials?
Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C

Background: Niemann-Pick type C (NPC) disease is a rare, progressive neurodegenerative disease that affects mainly the brain, liver, and spleen but also other parts of the body. There is no cure for NPC, and symptoms only get worse over time. Symptoms can include seizures, difficulty moving or talking, or dementia. But symptoms can vary among different people with the disease. Some may have seizures, while ot...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation

Summary: The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). ...